期刊
NEUROLOGY AND THERAPY
卷 11, 期 3, 页码 1439-1443出版社
SPRINGER LONDON LTD
DOI: 10.1007/s40120-022-00376-2
关键词
Neuromyelitis optica spectrum disorder; Aquaporin-4; Eculizumab; Satralizumab; Inebilizumab; Network meta-analysis; Matching-adjusted indirect comparison; Randomized controlled trials